Understand when and how to submit the active ingredients notification.
Under the Health Products (Active Ingredients) Regulations 2023, you do not need to apply for dealer licences for the manufacture, import and wholesale supply of active ingredients for use in the manufacture of a relevant health product (i.e., therapeutic product, Class 2 cell, tissue or gene therapy product, or medical device) for clinical research/clinical trial use, regardless of whether the clinical research/clinical trial is conducted in Singapore or overseas.
This is provided an active ingredient notification is made to HSA prior to the import or supply of active ingredients, as summarised in the table below:
Import of Active Ingredients
Supply of Active Ingredients by a local manufacturer of the Active Ingredient(s)
You do not need to make an active ingredient notification if you are already an importer or local manufacturer who holds a valid licence that allows you to import or supply the active ingredient for use in the manufacture of a health product.
Active ingredients notification form
If the active ingredient comprises any of the following substances, additional requirements apply, as indicated in the table below:
The active ingredients regulations are intended to ensure supply chain integrity. It is critical for local importers and wholesalers of active ingredients used to manufacture relevant health products in Singapore to ensure proper record keeping, labelling , disposal and transportation of the active ingredients.
Refer to the Health Products (Active Ingredients) Regulations 2023 for more information.
Regulatory Overview
Licensing and certification of importers and wholesalers
Licensing and certification of manufacturers
Certificate of a Pharmaceutical Product
Active ingredients used in Clinical Research/Clinical Trial
Guidance documents
Fees and turnaround time
PRISM (Active ingredients)
Infosearch